TABLE III.
Factors Associated With Anemia Over the Course of Therapy in Patients Coinfected With HIV and HCV
| Baseline factor | Odds ratio | P-value |
|---|---|---|
| ITPA deficiency | 0.5 | 0.263 |
| Age | 1.032 | 0.356 |
| Gender | 0.614 | 0.429 |
| BMI | 0.879 | 0.071 |
| Baseline HIV VL (Log10) | 1.08 | 0.823 |
| Baseline HCV VL (Log10) | 1.005 | 0.987 |
| Baseline Hgb (g/dl) | 0.518 | 0.008 |
| Fibrosis | 1.137 | 0.543 |
| Creatine | 0.398 | 0.616 |
| Platelet count | 0.998 | 0.475 |
| CD4 count | 0.99 | 0.502 |
| CD4% | 1.015 | 0.57 |
| AZT use | 1.957 | 0.339 |
P values < 0.05 are shown in bold.